EMHA Calendar
All EMHA Members
EMHA News
European Civic Prize on Chronic Pain
16/10/2018 Active Citizenship Network launch the second edition of the bi-annual research-project at the European level “EU Civic Prize on Chronic Pain - Colle...
Patient Solidarity Day 2018
16/10/2018 On Friday 7 December 2018, patient advocates and stakeholders from all world regions will stand together, united in a celebration of Patient Solida...
Lilly’s Emgality Approved
15/10/2018 INDIANAPOLIS, Sept. 27, 2018 Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved Emgality&#x...
EMHA New Corporate Website
05/10/2018 European Migraine and Headache Alliance (EMHA) has launched a new version of its corporate website: www.emhalliance.org The website has a number of ne...
The #MigrainePose “Trend”
11/09/2018 How can this even be a trend!!!!???? Headache Pose? Migraine Pose? What is this supposed to mean? Migraine is not a pose but a neurological d...
Coming Together to Put Patients First in Headache Treatment
04/09/2018 Stephani Sutherland, PhD, is a neuroscientist, yogi, and freelance writer in Southern California. Migraine and other severe headache disorders affec...
100 Million Neurons Found Outside The Brain
20/08/2018 Trupti Gokani, MD is a neurologist and author of The Mysterious Mind. She practices a blend of Western and Eastern medicine which focuses on the root...
Estrogen may explain why women suffer more often migraines
16/08/2018 Spanish researchers have discovered that the role of this sex hormone around the trigeminal nerve could be key in migraine episodes, which could expla...
New Aimovig Medication Approved
31/07/2018 Novartis marks a new era for migraine patients with the EU approval of Aimovig®, a first-of-its- kind treatment specifically designed for migraine pr...
Why is migraine still a big mystery to science
16/07/2018 Very common especially in women, these intense headaches are still a great medical mystery whose causes are not enlightened. Very common especially in...
What is EMHA?
The European Migraine & Headache Alliance is a non-profit, patient umbrella group which was launched in 2006. Since then, the Alliance has grown to represent 25 patient groups from across the continent.
The development of European umbrella organisations is a natural progression with more relevance for European nations.
About Headache
Headache disorders are among the most common disorders of the nervous system. These include tension-type headache (TTH), migraine and chronic daily headache syndromes as well as the more rare disorders, cluster headache and trigeminal neuralgia.
EMHA Data charts
Statistical data
In 2010, EHA launched its Madrid Manifesto for Migraine/ Headache Disorders at the Spanish Parliament to mark European Migraine Day of Action. This document outlined our 5-year objectives to improve migraine management, education and awareness across Europe.
Projects
EMHA is the result of the need of making society know the different types of migraine that exist and that currently are not receiving the importance they deserve. EMHA fights for the human rights, that is why is present in activities and events that are relevant for headache issues. Trying to give voice for those ones who need it. EMHA works as well in finding a way to mitigate migraine, by joining forces and strengthening partnerships which are aiming the same objective.
